Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome: the MONITOR ACS-Epic 13 randomized trial.

ABSTRACT:

Aims

Patients with acute coronary syndrome (ACS) may experience adverse events during follow-up. Previous trials have shown that asymptomatic arrhythmias preceded these adverse events in a substantial proportion of patients. Ambulatory remote monitoring may allow early detection of electrocardiographic alterations with therapeutic and prognostic implications. This study aims to evaluate the efficacy of remote monitoring in this population.

Methods and results

This is a single-center, randomized controlled trial designed to evaluate the efficacy of 12-month monitoring of high-risk patients after ACS. High risk was defined by a GRACE score over 118 and a CHA₂DS₂-VASc score over 2. In the intervention arm, two different systems were implemented: an implant

SUBMITTER: De La Torre Hernandez JM 

PROVIDER: S-EPMC12400330 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature